AU2001243220A1 - Methods of screening for compounds that modulate blood vessel formation - Google Patents

Methods of screening for compounds that modulate blood vessel formation

Info

Publication number
AU2001243220A1
AU2001243220A1 AU2001243220A AU4322001A AU2001243220A1 AU 2001243220 A1 AU2001243220 A1 AU 2001243220A1 AU 2001243220 A AU2001243220 A AU 2001243220A AU 4322001 A AU4322001 A AU 4322001A AU 2001243220 A1 AU2001243220 A1 AU 2001243220A1
Authority
AU
Australia
Prior art keywords
screening
compounds
methods
blood vessel
vessel formation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001243220A
Inventor
W. Scott Argraves
Christopher J. Drake
Paul A. Fleming
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MUSC Foundation for Research Development
Original Assignee
MUSC Foundation for Research Development
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MUSC Foundation for Research Development filed Critical MUSC Foundation for Research Development
Publication of AU2001243220A1 publication Critical patent/AU2001243220A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5073—Stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0605—Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5064—Endothelial cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00—Use of cells in diagnostics
    • C12N2503/02—Drug screening
AU2001243220A 2000-02-23 2001-02-23 Methods of screening for compounds that modulate blood vessel formation Abandoned AU2001243220A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US51068700A 2000-02-23 2000-02-23
US09510687 2000-02-23
PCT/US2001/005661 WO2001063281A1 (en) 2000-02-23 2001-02-23 Methods of screening for compounds that modulate blood vessel formation

Publications (1)

Publication Number Publication Date
AU2001243220A1 true AU2001243220A1 (en) 2001-09-03

Family

ID=24031751

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001243220A Abandoned AU2001243220A1 (en) 2000-02-23 2001-02-23 Methods of screening for compounds that modulate blood vessel formation

Country Status (3)

Country Link
US (1) US20030134266A1 (en)
AU (1) AU2001243220A1 (en)
WO (1) WO2001063281A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003205266A1 (en) * 2002-01-22 2003-09-02 Advanced Cell Technology, Inc. Stem cell-derived endothelial cells modified to disrupt tumor angiogenesis
MXPA04009996A (en) 2002-04-12 2005-07-01 Celgene Corp Methods for identification of modulators of angiogenesis, compounds discovered thereby, and methods of treatment using the compounds.
AU2003286746A1 (en) 2002-10-29 2004-05-25 Rigel Pharmaceuticals, Inc. Modulators of angiogenesis and tumorigenesis
WO2005010524A1 (en) * 2003-06-04 2005-02-03 Curis, Inc. Stem cell-based methods for identifying and characterizing agents
US8697139B2 (en) 2004-09-21 2014-04-15 Frank M. Phillips Method of intervertebral disc treatment using articular chondrocyte cells
CN106497863B (en) * 2015-09-07 2019-10-11 江苏齐氏生物科技有限公司 A kind of separation, purifying and the cultural method of cornea of rats endothelial cell

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6828144B2 (en) * 1996-04-09 2004-12-07 Wisconsin Alumni Research Foundation Method of observing vasculogenesis in vitro using cultured allantois
WO1998035020A2 (en) * 1997-02-10 1998-08-13 The Presidents And Fellows Of Harvard College Methods for modulating hematopoiesis and vascular growth

Also Published As

Publication number Publication date
WO2001063281A1 (en) 2001-08-30
US20030134266A1 (en) 2003-07-17

Similar Documents

Publication Publication Date Title
AU2557500A (en) Methods of making compounds
AU2002213308A1 (en) Methods of selecting compounds for modulation of bladder function
AU2002237527A1 (en) Method of synthesizing camptothecin-relating compounds
AU2002230770A1 (en) Graft having region for biological seal formation
AU2792499A (en) Improved methods for synthesis of oligonucleotides
AU5468499A (en) 3-methylidenyl-2-indolinone modulators of protein kinase
AU1492901A (en) Methods of screening for agents which inhibit aggregation of polypeptides
AU2001291019A1 (en) Method of modulating neovascularization
AU2002305333A1 (en) Compounds and methods for the modulation of cd154
AU2002306918A1 (en) Methods of modulating angiogenesis
AU3596199A (en) Treatment of celiac disease
AU2002364124A1 (en) Methods for identifying modulators of apoptosis
AU2001271706A1 (en) Use of substituted indole compounds for treating breast disorders
EP1463820A4 (en) Method of screening compounds
HK1049618A1 (en) Modulation of bone formation
IL161406A0 (en) Method for the formation of ibuprofen crystals
AU2001243220A1 (en) Methods of screening for compounds that modulate blood vessel formation
AU5536599A (en) Process for the preparation of neotame
AU3005500A (en) Methods of screening for antiviral compounds
AU2001230365A1 (en) Method of screening compounds for biological activity
AU2001283463A1 (en) Methods of diagnosis of cancer and screening for cancer modulators
AU2002337601A1 (en) Process for the preparation of simvastatin
AU3098099A (en) Biological modification of vaso-occlusive devices
AU8317901A (en) Methods for modulating multiple lineage kinase proteins and screening compounds which modulate multiple linease kinase proteins
AU2002247215A1 (en) Method for screening compounds